Wei-Feng Wang

609 total citations
36 papers, 468 citations indexed

About

Wei-Feng Wang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Wei-Feng Wang has authored 36 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Wei-Feng Wang's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cyclopropane Reaction Mechanisms (3 papers). Wei-Feng Wang is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cyclopropane Reaction Mechanisms (3 papers). Wei-Feng Wang collaborates with scholars based in China, United States and United Kingdom. Wei-Feng Wang's co-authors include Xuanxue Mo, Gordon Davies, Jin‐Bao Peng, Hongyan Ding, Qiang Dong, Qi Yang, Qiudan Chen, Mei Cui, Xiaotong Chen and Shihao Zhuang and has published in prestigious journals such as Journal of Clinical Oncology, Langmuir and ACS Catalysis.

In The Last Decade

Wei-Feng Wang

34 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei-Feng Wang China 13 183 106 67 50 44 36 468
Jian Qin China 11 219 1.2× 93 0.9× 60 0.9× 52 1.0× 16 0.4× 21 442
Tzu‐Yu Lin Taiwan 11 199 1.1× 46 0.4× 29 0.4× 35 0.7× 19 0.4× 21 401
Jieping Zhang China 13 320 1.7× 128 1.2× 148 2.2× 51 1.0× 13 0.3× 37 555
Atsushi CHINO Japan 10 192 1.0× 158 1.5× 15 0.2× 63 1.3× 8 0.2× 76 594
Huaping Xiong China 11 526 2.9× 255 2.4× 31 0.5× 69 1.4× 6 0.1× 21 746
Jia Hu China 19 418 2.3× 73 0.7× 51 0.8× 142 2.8× 24 0.5× 55 934
Yanzhou Zhang China 12 268 1.5× 66 0.6× 24 0.4× 18 0.4× 9 0.2× 19 474
В. Е. Шевченко Russia 13 207 1.1× 77 0.7× 25 0.4× 114 2.3× 13 0.3× 57 491
Mengchao Wang China 10 101 0.6× 84 0.8× 19 0.3× 29 0.6× 7 0.2× 26 333

Countries citing papers authored by Wei-Feng Wang

Since Specialization
Citations

This map shows the geographic impact of Wei-Feng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Feng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Feng Wang more than expected).

Fields of papers citing papers by Wei-Feng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Feng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Feng Wang. The network helps show where Wei-Feng Wang may publish in the future.

Co-authorship network of co-authors of Wei-Feng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Feng Wang. A scholar is included among the top collaborators of Wei-Feng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Feng Wang. Wei-Feng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Qiudan, et al.. (2025). Targeting the dual miRNA/BMP2 network: LncRNA H19-mediated temozolomide resistance unveils novel therapeutic strategies in glioblastoma. Frontiers in Oncology. 15. 1577221–1577221. 3 indexed citations
2.
Wang, Wei-Feng, Min Jiang, Ying Liu, et al.. (2025). Application of 2D polymerase chain reaction for single-tube detection of high-risk human papillomaviruses. Frontiers in Microbiology. 16. 1528094–1528094. 2 indexed citations
3.
Li, Lin, et al.. (2024). Palladium-Catalyzed Cascade Carbonylation Reaction: Synthesis of Fused Isoindolinones. Organic Letters. 26(27). 5625–5629. 4 indexed citations
4.
Li, Yueying, et al.. (2024). Prognostic value of coagulation markers in patients with colorectal cancer: A prospective study. Health Science Reports. 7(2). e1553–e1553. 3 indexed citations
5.
6.
Wang, Wei-Feng, Jie Zhang, Yan Chen, et al.. (2022). Detection of Five Types of HPV Genotypes Causing Anogenital Warts (Condyloma Acuminatum) Using PCR-Tm Analysis Technology. Frontiers in Microbiology. 13. 857410–857410. 4 indexed citations
7.
Li, Lin, et al.. (2022). Palladium Catalyzed Dicarbonylation of α-Iodo-Substituted Alkylidenecyclopropanes: Synthesis of Carbamoyl Substituted Indenones. Organic Letters. 24(30). 5624–5628. 17 indexed citations
8.
Wang, Wei-Feng, Qiudan Chen, Jianguang Wang, et al.. (2021). The level of thymic stromal lymphopoietin and its gene polymorphism are associated with rheumatoid arthritis. Immunobiology. 226(2). 152055–152055. 1 indexed citations
9.
10.
Lü, Meiling, Lei Yu, Yanrong Yang, et al.. (2021). Hayatine inhibits amino acid-induced mTORC1 activation as a novel mTOR-Rag A/C interaction disruptor. Biochemical and Biophysical Research Communications. 583. 71–78. 2 indexed citations
11.
Bao, Meiyu, et al.. (2021). Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer. Frontiers in Immunology. 12. 722807–722807. 17 indexed citations
12.
Wang, Wei-Feng, Xuan Wu, Ke Li, et al.. (2020). Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC. Clinica Chimica Acta. 514. 8–14. 9 indexed citations
13.
Wang, Wei-Feng & Yilong Zhang. (2020). PfSWIB, a potential chromatin regulator for var gene regulation and parasite development in Plasmodium falciparum. Parasites & Vectors. 13(1). 48–48. 7 indexed citations
14.
Qiang, Sujing, Jie Zhou, Kesheng Wang, et al.. (2020). Knockout of farnesoid X receptor aggravates process of diabetic cardiomyopathy. Diabetes Research and Clinical Practice. 161. 108033–108033. 11 indexed citations
15.
Chang, Zhengyan, Runzhi Huang, Jiehan Li, et al.. (2020). The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis. Frontiers in Cell and Developmental Biology. 8. 688–688. 36 indexed citations
16.
Lin, Jie, Yuehua Li, Hao Zou, et al.. (2020). The alteration of TERT in 10,000 Chinese patients with solid tumors.. Journal of Clinical Oncology. 38(15_suppl). e13655–e13655. 1 indexed citations
17.
Quan, Hui, Qiudan Chen, Kesheng Wang, et al.. (2020). Exendin-4 Reversed the PC12 Cell Damage Induced by circRNA CDR1as/miR-671/GSK3β Signaling Pathway. Journal of Molecular Neuroscience. 71(4). 778–789. 6 indexed citations
18.
Wang, Wei-Feng, et al.. (2016). The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia. Journal of Neuroinflammation. 13(1). 204–204. 39 indexed citations
19.
Wang, Wei-Feng, et al.. (2014). Mechanically and Chemically Tunable Cell Culture System for Studying the Myofibroblast Phenotype. Langmuir. 30(19). 5481–5487. 28 indexed citations
20.
Wang, Wei-Feng, et al.. (2013). PIK3CA hypomethylation plays a key role in activation of the PI3K/AKT pathway in esophageal cancer in Chinese patients. Acta Pharmacologica Sinica. 34(12). 1560–1567. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian Qin Breakdown of academic impact, for papers by Tzu‐Yu Lin Breakdown of academic impact, for papers by Jieping Zhang Breakdown of academic impact, for papers by Atsushi CHINO Breakdown of academic impact, for papers by Huaping Xiong Breakdown of academic impact, for papers by Jia Hu Breakdown of academic impact, for papers by Yanzhou Zhang Breakdown of academic impact, for papers by В. Е. Шевченко Breakdown of academic impact, for papers by Mengchao Wang
Rankless by CCL
2026